Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Eur J Surg Oncol ; 42(9): 1268-77, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26947960

ABSTRACT

INTRODUCTION: We evaluated the impacts of a series of novel histopathological factors on clinical-surgical outcomes and survival of patients who underwent surgery for colorectal cancer liver metastasis, with and without neoadjuvant chemotherapy. MATERIALS AND METHODS: A prospective database including 150 consecutive patients who underwent 183 hepatic resections for metastatic colorectal cancer was evaluated. Among them, 74 (49.3%) received neoadjuvant chemotherapy before surgery. The histopathological factors studied were: a) microsatellitosis, b) type and pattern of tumour growth, c) nuclear grade and the number of mitoses/mm(2), d) perilesional pseudocapsule, e) intratumoural fibrosis, f) lesion cellularity, g) hypoxic-angiogenic perilesional growth pattern, and h) the tumour normal interface. RESULTS: Three or more metastatic lesions, R1 resection margins, and <50% tumour necrosis were prognostic factors for a worse OS, but only the former was confirmed to be an independent prognostic factor in the multivariate analysis. Furthermore, tumour fibrosis <40% and cellularity >10% were predictive of a worse neoadjuvant therapy response, but these findings were not confirmed in the multivariate analysis. Finally, tumour necrosis <50%, cellularity >10%, and TNI >0.5 mm were prognostic factors for a worse DFS and AS in the univariate but not in the multivariate analysis. CONCLUSIONS: Several factors seem to influence the outcomes of surgery for colorectal cancer liver metastasis, especially the number of the lesions, the margins of resection, the percentage of necrosis and fibrosis, as well as the cellularity and the TNI.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma/pathology , Colorectal Neoplasms/pathology , Liver Neoplasms/pathology , Liver/pathology , Antibodies, Monoclonal/administration & dosage , Bevacizumab/administration & dosage , Capecitabine , Carcinoma/secondary , Carcinoma/therapy , Cetuximab/administration & dosage , Databases, Factual , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Fibrosis , Fluorouracil/analogs & derivatives , Fluorouracil/therapeutic use , Hepatectomy , Humans , Leucovorin/therapeutic use , Liver/surgery , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Metastasectomy , Mitotic Index , Multivariate Analysis , Necrosis , Neoadjuvant Therapy , Neoplasm Grading , Organoplatinum Compounds/therapeutic use , Oxaloacetates , Panitumumab , Prognosis , Retrospective Studies , Tumor Burden
2.
Clin. transl. oncol. (Print) ; 16(3): 234-242, mar. 2014.
Article in English | IBECS | ID: ibc-127730

ABSTRACT

Colorectal cancer (CRC) incidence has increased during the past decades in Spain, being the first malignant tumour in incidence. Observed mortality for CRC is mainly due to liver and lung metastases. The only curative treatment is surgery; new surgical techniques and neoadjuvant treatments have increased the number of surgery candidate patients. Patients should be managed with a multidisciplinary approach that includes imaging techniques, chemotherapy, surgery and pathological assessment. As an answer to this approach, a group of pathology experts interested on CRC liver metastases aimed to review the diagnosis and prognosis of liver mestastases and developed practical recommendations for its assessment. The expert group revised the current literature and prepared questions to be discussed based on available evidence and on their clinical practise. As a result, recommendations for the assessment of tumour regression of liver metastases are proposed, which could be implemented in oncology centres allowing assessment standardisation for these patients. Prospective multi-center studies to evaluate these recommendations validity will further contribute to improve the standard care of CRC liver metastases patients (AU)


No disponible


Subject(s)
Humans , Male , Female , Colorectal Neoplasms/pathology , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Neoadjuvant Therapy , Liver Neoplasms/secondary , Spain
3.
Clin Transl Oncol ; 16(3): 234-42, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24019036

ABSTRACT

Colorectal cancer (CRC) incidence has increased during the past decades in Spain, being the first malignant tumour in incidence. Observed mortality for CRC is mainly due to liver and lung metastases. The only curative treatment is surgery; new surgical techniques and neoadjuvant treatments have increased the number of surgery candidate patients. Patients should be managed with a multidisciplinary approach that includes imaging techniques, chemotherapy, surgery and pathological assessment. As an answer to this approach, a group of pathology experts interested on CRC liver metastases aimed to review the diagnosis and prognosis of liver mestastases and developed practical recommendations for its assessment. The expert group revised the current literature and prepared questions to be discussed based on available evidence and on their clinical practise. As a result, recommendations for the assessment of tumour regression of liver metastases are proposed, which could be implemented in oncology centres allowing assessment standardisation for these patients. Prospective multi-center studies to evaluate these recommendations validity will further contribute to improve the standard care of CRC liver metastases patients.


Subject(s)
Colorectal Neoplasms/pathology , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Neoadjuvant Therapy , Female , Humans , Liver Neoplasms/secondary , Male , Spain
9.
Actas Dermosifiliogr ; 101(2): 168-72, 2010 Mar.
Article in Spanish | MEDLINE | ID: mdl-20223160

ABSTRACT

Galli-Galli disease is a rare genodermatosis currently regarded as an acantholytic variant of Dowling-Degos disease. The 2 diseases have the same clinical features: reticular hyperpigmented macules in the great skin folds, erythematous scaly papules and plaques, comedo-like lesions, and pitted perioral scars, and the only differentiating characteristic is the histological finding of acantholysis, usually without dyskeratosis. We describe the case of a patient with hyperpigmented papules in the skin folds as the only sign of Galli-Galli disease, and we present a review of the literature.


Subject(s)
Acantholysis/diagnosis , Hyperpigmentation/diagnosis , Lichenoid Eruptions/diagnosis , Acantholysis/genetics , Acantholysis/pathology , Adult , Buttocks , Condylomata Acuminata/diagnosis , Diagnostic Errors , Female , Genital Neoplasms, Female/diagnosis , Groin , Humans , Hyperpigmentation/genetics , Hyperpigmentation/pathology , Lichenoid Eruptions/genetics , Lichenoid Eruptions/pathology , Neck
10.
Actas dermo-sifiliogr. (Ed. impr.) ; 101(2): 168-172, mar. 2010. tab, ilus
Article in Spanish | IBECS | ID: ibc-78495

ABSTRACT

La enfermedad de Galli-Galli (EGG) es una genodermatosis rara considerada actualmente como la variante acantolítica de la enfermedad de Dowling-Degos (EDD), con la que comparte sus manifestaciones clínicas: hiperpigmentación reticular en grandes pliegues cutáneos, pápulas y placas eritemato-descamativas, lesiones tipo comedón y cicatrices acneiformes peribucales. El hallazgo histológico de acantólisis, generalmente en ausencia de disqueratosis, constituye el único elemento diferenciador de ambas. Resumen: Presentamos el caso de una paciente con pápulas flexurales hiperpigmentadas en pliegues como único hallazgo de EGG y revisamos la literatura (AU)


Galli-Galli disease is a rare genodermatosis currently regarded as an acantholytic variant of Dowling-Degos disease. The 2 diseases have the same clinical features: reticular hyperpigmented macules in the great skin folds, erythematous scaly papules and plaques, comedo-like lesions, and pitted perioral scars, and the only differentiating characteristic is the histological finding of acantholysis, usually without dyskeratosis. We describe the case of a patient with hyperpigmented papules in the skin folds as the only sign of Galli-Galli disease, and we present a review of the literature (AU)


Subject(s)
Humans , Female , Adult , Lichenoid Eruptions/complications , Lichenoid Eruptions/diagnosis , Lichenoid Eruptions/therapy , Acantholysis/complications , Acantholysis/diagnosis , Hyperpigmentation/complications , Hyperpigmentation/diagnosis , Hyperpigmentation/therapy , Acneiform Eruptions/complications , Acneiform Eruptions/diagnosis , Biopsy/methods , Fluorescent Antibody Technique, Direct/methods
12.
Rev. esp. patol ; 34(2): 157-163, abr. 2001. ilus
Article in Es | IBECS | ID: ibc-7897

ABSTRACT

Presentamos el caso de una mujer de 38 años con tumoración mamaria bilateral y antecedentes de diabetes mellitus insulinodependiente (DMID). Las piezas remitidas son diagnosticadas de mastopatía diabética, lesión benigna de la mama relacionada con la DMID y otras alteraciones autoinmunes. A pesar de su benignidad tiene una alta tasa de recidiva, lo que unido a su aspecto radiográfico incierto obliga en muchas ocasiones a actitudes terapéuticas agresivas. Creemos importante recordar el comportamiento biológico y las características histológicas de esta enfermedad para establecer una estrategia diagnóstica/terapéutica más acorde con la realidad de esta lesión, empleando la PAAF como herramienta óptima de seguimiento (tras el diagnóstico definitivo por biopsia) en detrimento de métodos más invasores (AU)


Subject(s)
Adult , Female , Humans , Keloid/pathology , Wolfram Syndrome/complications , Wolfram Syndrome/diagnosis , Wolfram Syndrome/physiopathology , Mammography/methods , Fibroadenoma/surgery , Fibroadenoma/diagnosis , Fibroadenoma/etiology , Fibroadenoma/pathology , Biopsy, Needle/methods , T-Lymphocytes/cytology , T-Lymphocytes/pathology , Immunohistochemistry/methods , Fibrosis/complications , Fibrosis/diagnosis , Fibrosis/pathology , Fibrosis , Fibrocystic Breast Disease/surgery , Fibrocystic Breast Disease/complications , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/etiology , Fibrocystic Breast Disease/pathology , Breast Neoplasms/complications , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Breast Neoplasms/etiology , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/etiology , Diabetes Mellitus, Type 1/pathology , Neoplasm Recurrence, Local/complications , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/pathology , Punctures/methods , Punctures , Oligodendroglia/cytology , Oligodendroglia/pathology , Breast/pathology , Breast Diseases/diagnosis , Breast Diseases/etiology , Breast Diseases/complications , Breast Diseases/pathology , Recurrence
13.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 27(10): 381-384, dic. 2000. tab, ilus
Article in Es | IBECS | ID: ibc-20968

ABSTRACT

La mastopatía diabética es una enfermedad benigna de la mama que afecta a pacientes con diabetes mellitus tipo 1 de larga evolución, habitualmente en localización subareolar, pudiendo ser bilateral y recidivando con gran frecuencia. Nosotros hemos querido acercar esta patología a los profesionales clínicos para, desde el conocimiento de la lesión poder realizar un abordaje terapéutico acorde con sus características de benignidad. Tras revisar toda la bibliografía, hemos hallado 9 series que representan un total de 90 casos, además de un nuevo caso de mastopatía diabética de aportación personal. Con estos datos realizamos una correlación clinicopatológica, destacando los criterios histológicos constituidos por fibrosis queloidea, lobulitis, ductitis y perivasculitis, así como la evolución clínica caracterizada por tumores mamarios de 2-10 cm, que pueden presentar imagen radiológica sospechosa, y son tributarias de PAAF o incluso biopsia. Es frecuente que estas masas sean resecadas quirúrgicamente, aunque en el plazo de unos meses hasta el 37 por ciento recidivan. Como conclusión, apuntamos la necesidad de pensar en esta entidad ante toda paciente con diabetes mellitus tipo 1 con tumor mamario, y recordamos la posible bilateralidad, así como la muy alta tasa de recurrencia, lo que unido a su benignidad nos lleva a recomendar, ante un diagnóstico de certeza, el control de estas lesiones por medio de PAAF, evitando la práctica de biopsias repetidas, que no aportarían mayor luz al diagnóstico (AU)


Subject(s)
Adult , Female , Humans , Control Groups , Autoimmune Diseases/complications , Autoimmune Diseases/diagnosis , Fibrocystic Breast Disease/complications , Fibrocystic Breast Disease/diagnosis , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/diagnosis , Fibrosis/complications , Fibrosis/etiology , Breast Diseases/complications , Breast Diseases/diagnosis , Breast Diseases
15.
Rev Clin Esp ; 191(4): 204-6, 1992 Sep.
Article in Spanish | MEDLINE | ID: mdl-1332146

ABSTRACT

Soft tissue sarcomas are neoplasms which envolve from mesodermic tissue, being characterized for their low incidence (1% of all malignant tumors), histologic heterogeneity and diverseness regarding their localization. We present a new case of this infrequent tumor: malignant fibrous histiocytoma of exceptional localization: mediastinum.


Subject(s)
Histiocytoma, Benign Fibrous/pathology , Mediastinal Neoplasms/pathology , Humans , Male , Middle Aged
16.
Acta Otorrinolaringol Esp ; 42(2): 103-9, 1991.
Article in Spanish | MEDLINE | ID: mdl-2059482

ABSTRACT

Age-adjusted mortality and incidence rates for larynx cancer were calculated in Soria (urban and rural areas), for the 1950-89 and 1981-89 periods respectively. Both mortality and incidence rates were higher in urban area (p less than 0.01), and in males (p less than 0.01). There has been no increase in the mortality trend for the 1950-89 period. Age-adjusted incidence rates for men in Soria are higher respect to those reported in other countries. Soria and Murcia rates are the lowest in Spain larynx cancer records, being Asturias rates the highest in the world (20.6 per 100,000 population).


Subject(s)
Laryngeal Neoplasms/epidemiology , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Laryngeal Neoplasms/mortality , Male , Middle Aged , Rural Population , Sex Factors , Spain/epidemiology , Urban Population
17.
Med Clin (Barc) ; 96(1): 6-10, 1991 Jan 12.
Article in Spanish | MEDLINE | ID: mdl-1850813

ABSTRACT

We analyze the clinical and histological features of 10 cases of malignant fibrous histiocytoma of soft tissue. Nine belonged to the pleomorphic-verticillate variety and one was myxoid. The initial clinical feature was a palpable mass in all cases except three with retroperitoneal localization, where constitutional symptoms predominated. After therapy (surgery in all, associated with radiotherapy in four), seven patients had local relapse and two had distant metastases. 50% died, with a mean survival of 13 months. We discuss the prognostic factors and the therapeutic approach, with emphasis on aggressive therapy and the need for radical surgery and postoperative adjuvant therapy.


Subject(s)
Histiocytoma, Benign Fibrous/pathology , Soft Tissue Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Histiocytoma, Benign Fibrous/diagnosis , Histiocytoma, Benign Fibrous/therapy , Humans , Male , Middle Aged , Soft Tissue Neoplasms/diagnosis , Soft Tissue Neoplasms/therapy
18.
Arch Esp Urol ; 42(5): 423-31, 1989 Jun.
Article in Spanish | MEDLINE | ID: mdl-2684046

ABSTRACT

We report on a 25-year-old patient diagnosed as having Bourneville tuberous sclerosis with a giant angiomyolipoma 16 X 12 cm. in diameter, and two small angiomyolipomas in the left kidney, multiple asymptomatic angiomas in the right kidney and two 1 cm. diameter angiomas in the liver. The presenting features were intense left-sided abdominal pain of sudden onset, frank hematuria, acute anemic syndrome, nausea and vomiting. Patient work up included x-ray of chest, abdomen, and skull, bilateral renal arteriography and ultrasound were diagnostic of Bourneville tuberous sclerosis with multiple bilateral renal angiomyolipomas. The hematologic and hemodynamic compromise and the almost completely absent intact parenchyma in her left kidney did not permit a conservative surgical procedure and the patient was submitted to a left nephrectomy. The patient had the following characteristic features of Bourneville's disease: epilepsy, intracranial calcifications on CT, sebaceous adenomas on face, fibromas under nails of left hand and foot, bony lesions in the form osteosclerosis and chylous pleural effusion. Her intelligence level was normal and no optic nerve phakomas were observed. The literature on angiomyolipoma and Bourneville's tuberous sclerosis is reviewed. The importance of using ultrasound and CT in combination to diagnose and follow up renal angiomyolipomas is highlighted. Treatment of angiomyolipomas must be based on two parameters: symptoms and size. Symptomatic angiomyolipomas warrant angiographic work up and selective arterial embolization or the most conservative surgical procedure possible (enucleation, partial nephrectomy). Asymptomatic angiomyolipomas warrant CT and/or ultrasound examination every 6 or 12 months depending on size.


Subject(s)
Adenoma/complications , Facial Neoplasms/complications , Hemangioma/complications , Kidney Neoplasms/complications , Lipomatosis, Multiple Symmetrical/complications , Tuberous Sclerosis/complications , Adult , Hemangioma/diagnostic imaging , Hemangioma/pathology , Humans , Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/pathology , Lipomatosis , Lipomatosis, Multiple Symmetrical/diagnostic imaging , Lipomatosis, Multiple Symmetrical/pathology , Radiography , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL